Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Solvay/Abbott Cholesterol Drug Reduces Amputations From Diabetes
Bloomberg
Tuesday, September 9, 2008 - 8:26am
tags:
Gilead's Long-Term Uptrend in Jeopardy?
Investopedia
Monday, September 8, 2008 - 9:53pm
tags:
Cubist Pharmaceuticals Provides Update on Advancing Product Pipeline
Yahoo
Monday, September 8, 2008 - 9:52pm
tags:
Mylan to retain specialty drug unit Dey, backs outlook
Marketwatch
Monday, September 8, 2008 - 5:50pm
tags:
The Coming Great Pharma Panic
Motley Fool
Monday, September 8, 2008 - 5:47pm
tags:
Xoma diabetes studies could lead to single monthly dose
Bizjournals.com
Monday, September 8, 2008 - 3:27pm
tags:
Biodel Sinks on Mixed Drug Study Results
The Street.com
Monday, September 8, 2008 - 3:26pm
tags:
Medivation's Attitude Warrants a Pullback
Seeking Alpha
Monday, September 8, 2008 - 3:24pm
tags:
FDA advisers say Pfizer drug would benefit some women with osteoporosis, despite risks
Yahoo/AP
Monday, September 8, 2008 - 3:23pm
tags:
Bristol-Myers and AstraZeneca say diabetes drug met objectives in 2 late-stage trials
Yahoo/AP
Monday, September 8, 2008 - 3:22pm
tags:
Glaxo's Viehbacher to leave after missing CEO job
Forbes
Monday, September 8, 2008 - 11:57am
tags:
Another FDA Safety Warning (Yawn.)
Motley Fool
Monday, September 8, 2008 - 11:42am
tags:
Biodel says Viaject met goals in diabetes trial, but India data sends stock to all-time low
Yahoo/AP
Monday, September 8, 2008 - 11:39am
tags:
Fannie, Freddie & Pharma: Resolution "Helps" Sector Stocks?
CNBC
Monday, September 8, 2008 - 11:38am
tags:
Medarex Receives Milestone Payment From Pfizer on IND Filing
Cafepharma Detailpiece
Monday, September 8, 2008 - 10:54am
tags:
Elan seeks second-round bids for €1bn EDT drug unit
Independent, Ireland
Monday, September 8, 2008 - 10:18am
tags:
Analyst's Comments Buoy PFE
Market Intelligence Center
Monday, September 8, 2008 - 10:09am
tags:
AMRI to receive $1.5M from Bristol-Myers
Bizjournals.com
Monday, September 8, 2008 - 10:07am
tags:
AstraZeneca says Saxagliptin improved glucose control
Marketwatch
Monday, September 8, 2008 - 9:09am
tags:
J&J Seeks Expanded U.S. Use of Doxil in Breast Cancer
Bloomberg
Monday, September 8, 2008 - 9:08am
tags:

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.